Arrowhead Pharmaceuticals Corp (ARWR)

9.77 -0.23 (2.30%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/2/18 *Est.)

Latest Headlines

Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis May 21, 2018 7:30 AM - BizWire Form SC 13G ARROWHEAD PHARMACEUTICAL Filed by: RTW INVESTMENTS, LP May 14, 2018 9:18 AM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Reports Dosing of 1st Hepatitis B Patient in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV May 14, 2018 7:34 AM - StreetInsider Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV May 14, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline May 11, 2018 7:30 AM - BizWire Arrowhead Research (ARWR) PT Raised to $4.50 at B.Riley/FBR May 9, 2018 8:40 AM - StreetInsider Arrowhead Research (ARWR) PT Raised to $9.50 at Chardan Capital Markets May 9, 2018 5:29 AM - StreetInsider Cantor Fitzgerald Upgrades Arrowhead Research (ARWR) to Overweight May 9, 2018 4:48 AM - StreetInsider Arrowhead Research (ARWR) PT Raised to $11 at Piper Jaffray May 9, 2018 2:23 AM - StreetInsider Form 10-Q ARROWHEAD PHARMACEUTICAL For: Mar 31 May 8, 2018 4:20 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: May 08 May 8, 2018 4:10 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Tops Q2 EPS by 1c, Miss on Revenues May 8, 2018 4:01 PM - StreetInsider Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results May 8, 2018 4:00 PM - BizWire Arrowhead Pharmaceuticals to Present Preclinical Data on Emerging Pipeline of RNAi Therapeutics May 1, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Apr 24 Filed by: GIVEN DOUGLAS B April 25, 2018 7:40 PM - SEC Filing Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results April 24, 2018 4:01 PM - BizWire Pre-Open Movers 04/11: (VHC) (LKM) (ARWR) Higher; (BW) (ALOG) (LAYN) Lower (more...) April 11, 2018 9:17 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Announces Clinical Data on ARC-520 at International Liver Congress 2018 April 11, 2018 7:06 AM - StreetInsider Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™ April 11, 2018 7:00 AM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Announces Multiple Presentations at The International Liver Congress March 28, 2018 7:32 AM - StreetInsider Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™ March 28, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 27 Filed by: Myszkowski Kenneth Allen March 27, 2018 7:46 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Commences Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B March 27, 2018 7:34 AM - StreetInsider Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B March 27, 2018 7:30 AM - BizWire Jefferies Starts Arrowhead Research (ARWR) at Buy March 27, 2018 4:15 AM - StreetInsider Form S-8 ARROWHEAD PHARMACEUTICAL March 22, 2018 6:04 AM - SEC Filing Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20, 2018 4:05 PM - BizWire Form 8-K ARROWHEAD PHARMACEUTICAL For: Mar 16 March 20, 2018 6:06 AM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 16 Filed by: Anzalone Christopher Richard March 16, 2018 6:10 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 13 Filed by: Anzalone Christopher Richard March 15, 2018 6:58 PM - SEC Filing Arrowhead Begins Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease March 12, 2018 7:30 AM - BizWire Arrowhead to Present at Barclays Global Healthcare Conference 2018 March 6, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 05 Filed by: GIVEN BRUCE D March 5, 2018 8:49 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 05 Filed by: Myszkowski Kenneth Allen March 5, 2018 8:47 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Reports Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22, 2018 7:34 AM - StreetInsider Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22, 2018 7:30 AM - BizWire Full Article List